Mieres, Asturias – Residents of Asturias now have increased access to a highly precise treatment for certain skin cancers thanks to the Hospital Vital Álvarez-Buylla’s permanent integration of Mohs surgery into its service offerings. This advanced technique allows surgeons to remove cancerous tissue while preserving as much healthy skin as possible, offering improved outcomes and cosmetic results for patients. The hospital has successfully completed ten Mohs procedures to date, all with positive results, marking a significant step forward in dermatological care within the region.
The implementation of Mohs surgery at the Hospital Vital Álvarez-Buylla addresses a critical need for specialized cancer treatment within the public healthcare system of Asturias. Previously, patients requiring this procedure often faced the necessity of traveling to other autonomous communities for care. This expansion not only streamlines access but also reduces the burden on patients and their families, offering a more convenient and efficient pathway to treatment.
What is Mohs Surgery?
Mohs surgery, named after dermatologist Frederic Mohs, is a specialized technique used to treat skin cancers, particularly those in cosmetically sensitive areas like the face, neck, and hands. The procedure involves meticulously removing the tumor layer by layer, with each layer immediately examined under a microscope by a pathologist. This real-time analysis allows the surgeon to precisely identify and eliminate any remaining cancer cells, minimizing the amount of healthy tissue removed. According to the American Academy of Dermatology, Mohs surgery boasts a high cure rate, particularly for basal cell and squamous cell carcinomas. American Academy of Dermatology – Mohs Surgery
The process is highly collaborative, requiring close coordination between dermatologists and anatomical pathologists. At the Hospital Vital Álvarez-Buylla, dermatologists remove the cancerous lesion in thin layers, which are then immediately sent to the pathology team for microscopic analysis. This rapid turnaround allows surgeons to determine if all cancer cells have been eradicated during the same intervention, significantly reducing the need for multiple surgeries. The hospital anticipates performing approximately two Mohs procedures per month, with the potential to increase based on patient demand.
Benefits for Patients and the Asturian Healthcare System
Álvaro Iglesias, a dermatologist at the Hospital Álvarez Buylla, emphasizes the significant advantages for patients. “Not only does this reduce the time spent in the operating room and waiting for results, but it also gives patients a 99% assurance that all of the tumor has been removed,” he explained. The precision of the technique also minimizes damage to surrounding healthy tissue, leading to improved cosmetic outcomes and faster healing times.
The integration of Mohs surgery at the Hospital Vital Álvarez-Buylla represents a substantial advancement for the Asturian public health system. Currently, the Hospital Universitario de Cabueñes in Gijón is the only other facility in Asturias offering this specialized treatment. By providing this service within the regional network, the hospital is reinforcing its commitment to delivering accessible, efficient, and patient-centered care to the community.
The team at Hospital Vital Álvarez-Buylla involved in performing the Mohs technique includes dermatologists Paula Penanes, Jimena Carrero, and Rebeca Pérez; pathologist Inés Gomez de la Riva; head of the Pathology Service, Ana María Gutiérrez Palacios; dermatologist Álvaro Iglesias; and pathology technician Bárbara Fernández Hevia.
Disclaimer: This article provides informational content about medical treatments and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
The expansion of Mohs surgery at the Hospital Vital Álvarez-Buylla signals a positive trend in specialized cancer care within Asturias. As the hospital continues to refine its protocols and meet the growing demand for this advanced treatment, it is poised to play a crucial role in improving outcomes for patients facing skin cancer diagnoses. We encourage readers to share this information and engage in discussions about advancements in dermatological care.
